Back to today’s briefing

Story perspectives

Genetic Mutation Linked to Anemia in IBD Patients

6/8/2025

38 7

Summary

Story summary

A groundbreaking study from the University of California, Riverside, uncovers a genetic mutation in the PTPN2 gene that exacerbates iron deficiency and anemia in patients with inflammatory bowel disease (IBD). This mutation hinders iron absorption, shedding light on the challenges faced with oral iron therapy. The findings advocate for personalized intravenous iron treatments to better support these patients.

1 of 1

Story summary

A groundbreaking study from the University of California, Riverside, uncovers a genetic mutation in the PTPN2 gene that exacerbates iron deficiency and anemia in patients with inflammatory bowel disease (IBD). This mutation hinders iron absorption, shedding light on the challenges faced with oral iron therapy. The findings advocate for personalized intravenous iron treatments to better support these patients.